A common gene mutation for Parkinson’s disease drives mislocalization of iron in activated microglia, according to a study published recently in PLOS Biology, by Mark Cookson of the National Institute on Aging and colleagues.
The Parkinson's Foundation announces the results of a survey measuring how people with Parkinson's disease (PD) are coping during the COVID-19 pandemic. Complete results are available in npj Parkinson's Disease.
Representatives from Cala Health Inc recently presented data demonstrating that Cala Trio therapy is safe and effective in improving tremors in patients with essential tremor (ET) when used at home, unsupervised, and under real-world conditions.
Recently developed MRI techniques used to more precisely target a small area in the brain linked to Parkinson’s disease and essential tremor may lead to better outcomes without surgery and with less risk of negative effects, a new study led by UT Southwestern researchers suggests.
Read More
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announces that Bill Rasmussen has joined its team to help speed a cure for Parkinson’s disease.
Read More
The US Food and Drug Administration has approved Kynmobi from Sunovion Pharmaceuticals Inc, formulated to treat “off” time, when Parkinson’s disease (PD) symptoms are not well controlled with oral medication.
Read More
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) launches an educational resource, “If I Knew Then What I Know Now: The Michael J. Fox Foundation Patient Council’s Guide for People Newly Diagnosed with Parkinson’s.”
Read More
Reprogramming a patient’s own skin cells to replace cells in the brain that are progressively lost during Parkinson’s disease (PD) is technically feasible, investigators from McLean Hospital and Massachusetts General Hospital (MGH) suggest, in the New England Journal of Medicine.
Read More
The American Parkinson Disease Association (APDA) announces the full schedule for the 2020 APDA Optimism Walks — a nationwide movement to mobilize and inspire people to step up and help put an end to Parkinson’s disease (PD).
Read More
A new generation of wearables in the funnel can monitor, encourage, and even treat people suffering from chronic neurological disorders such as stroke, cerebral palsy, and even the essential tremors that come with Parkinson’s Disease. They’re small, they’re fierce, and they are all in for conquering learned non-use.
Read More
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) is launching a limited-series podcast beginning Wednesday, May 6, 2020, designed to help people with Parkinson’s disease and their care partners navigate their way through the COVID-19 pandemic.
Read More
The Michael J. Fox Foundation for Parkinson’s Research has released “Together, We Can Solve the Parkinson’s Puzzle,” a new video resource to help empower patients and families to participate in Parkinson’s research.
Read More
Three neurological cases that could have failed became success stories through a “supply and demand” approach to rehabilitation. Find out what happened in this 15-minute TEDx Talk.
Read More
Evidence suggests that Parkinson’s disease is partly an autoimmune disease. In addition, signs of autoimmunity can appear in Parkinson’s disease patients years before their official diagnosis, researchers from La Jolla Institute for Immunology suggest in Nature Communications.
Read More
Research suggests that improvements in dynamic balance can assist in the reduction of falls. These researchers test a robust approach to balance training and assessment within a senior population.
Read More
Researchers from Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital report they may have found the brain cell that triggers tremor and how to control it.
Read More
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) launches its fourth annual Fox Trot 5K Run/Walk Series, a series of eight community events across the United States in support of a cure for Parkinson’s disease.
Read More
MedRhythms announces the advancement of its pipeline of neurologic rehabilitation products in multiple sclerosis (MS) and Parkinson’s disease (PD).
Read More